IP Library Granted Patent US 11,540,981
Granted Patent B2
US 11,540,981 · App. 12/520,759 · Granted Jan 3, 2023

Nanoemulsion formulation with improved stability and cell penetration

Inventor: Montserrat Foguet Roca (Leverkusen, DE)
Assignee: BIOFRONTERA BIOSCIENCE GMBH
A61K8/06A61K8/34A61K8/375A61K8/44A61K8/4993A61K8/553A61K9/107A61Q19/00B82Y5/00A61K2800/21A61K2800/413
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,540,981
App. No.
12/520,759
Granted
Jan 3, 2023
Kind
B2
Abstract

The present invention relates to a nanoemulsion comprising at least one aqueous component and a carrier, wherein the carrier comprises at least one lipophilic component, at least one surfactant and at least one alcohol. The present invention further relates to a composition comprising said nanoemulsion and an active agent. In particular, the composition is present as a gel and the active agent is 5-aminolevulinic acid, a derivative, precursor and/or metabolite thereof. The invention further relates to the preparation of said nanoemulsion and/or composition and to their use for the treatment of dermatological diseases, virus-associated diseases as well as diseases associated with cell proliferation, in particular, tumor diseases and/or psoriasis. The present invention is further directed to the use of said nanoemulsion in cosmetics.

Claims (44)

1. A topical gel composition, the composition comprising:

3-15% by weight 5-aminolevulinic acid hydrochloride based on the total weight of the composition;

1-3% by weight xanthan gum based on the total weight of the composition;

1% to 3% by weight of at least two preservatives, one of the preservatives being propylene glycol based on the total weight of the composition; and

a nanoemulsion;

wherein the nanoemulsion is an oil-in-water nanoemulsion comprising:

50-98% by weight water based on the total weight of the nanoemulsion;

1-30% by weight surfactant and co-surfactant together wherein the surfactant is soy lecithin and the co-surfactant is polysorbate 80 based on the total weight of the nanoemulsion;

0.1-15% by weight triglycerides based on the total weight of the nanoemulsion;

1-2% by weight isopropyl alcohol based on the total weight of the nanoemulsion; and

5-30 mM phosphate buffer;

and wherein the nanoemulsion comprises particles with a mean diameter from 5 nm to 35 nm, with a particle size standard deviation from the mean of about 5 nm, prior to incorporation into the topical gel composition.

2. The topical gel composition of claim 1 , wherein the amount of 5-aminolevulinic acid hydrochloride is about 10% w/w based on the total weight of the composition.

3. The topical gel composition of claim 1 , wherein the amount of nanoemulsion is from about 10% to about 30% w/w based on the total weight of the composition.

4. The topical gel composition of claim 1 , wherein the amount of triglycerides in the nanoemulsion is from about 1% to about 8% w/w based on the total weight of the nanoemulsion.

5. The topical gel composition of claim 1 , wherein the soy lecithin has a phosphatidylcholine content of at least 90% by weight based on the total weight of the soy lecithin.

6. A topical gel composition, the composition comprising:

about 10% by weight 5-aminolevulinic acid hydrochloride based on the total weight of the composition;

1-3% by weight xanthan gum based on the total weight of the composition;

1% to 3% by weight of at least two preservatives, one of the preservatives being propylene glycol based on the total weight of the composition; and

a nanoemulsion;

wherein the nanoemulsion is an oil-in-water nanoemulsion comprising:

water;

1-30% by weight surfactant and co-surfactant together wherein the surfactant is soy lecithin and the co-surfactant is polysorbate 80 based on the total weight of the nanoemulsion;

0.1-15% by weight triglycerides based on the total weight of the nanoemulsion;

1-2% by weight isopropyl alcohol based on the total weight of the nanoemulsion; and

5-30 mM phosphate buffer;

wherein the soy lecithin has a phosphatidylcholine content of at least 90% by weight based on the total weight of the soy lecithin,

and wherein the nanoemulsion comprises particles with a mean diameter from 5 nm to 35 nm, with a particle size standard deviation from the mean of about 5 nm, prior to incorporation into the topical gel composition.

7. The topical gel composition of claim 6 , wherein the amount of 5-aminolevulinic acid hydrochloride is 10% w/w based on the total weight of the composition.

8. The topical gel composition of claim 6 , wherein the amount of nanoemulsion is from about 10% to about 30% w/w based on the total weight of the composition.

9. The topical gel composition of claim 6 , wherein the amount of triglycerides in the nanoemulsion is from about 1% to about 8% w/w based on the total weight of the nanoemulsion.

10. A topical gel composition, the composition comprising:

about 10% by weight 5-aminolevulinic acid hydrochloride based on the total weight of the composition;

2-3% by weight xanthan gum based on the total weight of the composition;

1% to 3% by weight of at least one preservative wherein the preservative comprises propylene glycol based on the total weight of the composition; and

a nanoemulsion;

wherein the nanoemulsion is an oil-in-water nanoemulsion comprising:

70-95% by weight water based on the total weight of the nanoemulsion;

about 1% by weight surfactant and co-surfactant together wherein the surfactant is soy lecithin and the co-surfactant is polysorbate 80 based on the total weight of the nanoemulsion;

0.1-1% by weight triglycerides based on the total weight of the nanoemulsion;

1-2% by weight isopropyl alcohol based on the total weight of the nanoemulsion; and

5-30 mM phosphate buffer;

and wherein the nanoemulsion comprises particles with a mean diameter from 5 nm to 35 nm, with a particle size standard deviation from the mean of about 5 nm, prior to incorporation into the topical gel composition.

Assignments (3)
CORRECTIVE ASSIGNMENT TO CORRECT THE EXECUTION DATE PREVIOUSLY RECORDED ON REEL 73509 FRAME 6. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 8, 2026
From: BIOFRONTERA BIOSCIENCE GMBH
To: BIOFRONTERA, INC.
Reel/Frame 075699/0753 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 5, 2025
From: BIOFRONTERA BIOSCIENCE GMBH
To: BIOFRONTERA, INC.
Reel/Frame 073509/0006 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 22, 2009
From: FOGUET ROCA, MONTSERRAT
To: BIOFRONTERA BIOSCIENCE GMBH
Reel/Frame 022858/0861 →
Priority Claims (1)
EP 06026698 · Dec 22, 2006 · regional
Continuity (1)
Related Publication 20090324727A1 · Dec 31, 2009
Cited By (2)
US 12,280,146 US 12,409,112